Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

116.18 +1.78 (+1.56%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Dexcom Inc

< Previous 1 2 3 Next >
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Dexcom Announces Upcoming Conference Presentations
From DexCom, Inc.
Via Business Wire
Dexcom Updates First Quarter 2022 Conference Call for April 28, 2022 at 5:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
Dexcom Reports First Quarter 2022 Financial Results
From DexCom, Inc.
Via Business Wire
DexCom Showcases Expanded CGM Portfolio at International ATTD Conference, Offering More Choice to People With Diabetes
From DexCom, Inc.
Via Business Wire
Dexcom Publishes Annual Sustainability Report
From DexCom, Inc.
Via Business Wire
Dexcom Schedules First Quarter 2022 Earnings Release and Conference Call for April 28, 2022 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
Dexcom Announces Four-for-One Forward Stock Split
From DexCom, Inc.
Via Business Wire
Dexcom G7 Receives CE Mark – Next-Generation Continuous Glucose Monitoring System to Revolutionize Diabetes Management
From DexCom, Inc.
Via Business Wire
Dexcom Announces Upcoming Virtual Conference Presentations
From DexCom, Inc.
Via Business Wire
Dexcom Reports Fourth Quarter and Fiscal Year 2021 Financial Results
From DexCom, Inc.
Via Business Wire
Dexcom G6 Continuous Glucose Monitoring System Now Covered in Alberta for Children and Youth Living With Diabetes
From Dexcom, Inc.
Via Business Wire
Dexcom Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call for February 10, 2022 at 4:30 p.m. Eastern Time.
From DexCom, Inc.
Via Business Wire
Dexcom Reports Preliminary, Unaudited Revenue for the Fourth Quarter 2021 and Summary Data from the Dexcom G7 U.S. Pivotal Trial
From DexCom, Inc.
Via Business Wire
Dexcom to Present at 40th Annual J.P. Morgan Healthcare Conference
From DexCom, Inc.
Via Business Wire
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Dexcom, Nick Jonas, Patti LaBelle and The Global Movement for Time in Range Invite the World to #SeeDiabetes This November
From Dexcom, Inc.
Via Business Wire
Dexcom Reports Third Quarter 2021 Financial Results
From DexCom, Inc.
Via Business Wire
Dexcom Schedules Third Quarter 2021 Earnings Release and Conference Call for October 28, 2021 at 4:30 p.m. Eastern Time
From Dexcom, Inc.
Via Business Wire
Desperate for Solutions, Diabetes and Obesity Healthcare Sectors Find Answers, Hope in Innovative Tech
Via Investor Brand Network
Exposures COVID-19
Non-insured Health Benefits Program Now Covers Dexcom G6 Continuous Glucose Monitoring System for Children and Adolescents on Intensive Insulin Therapy
From Dexcom, Inc.
Via Business Wire
Dexcom Announces Upcoming Virtual Conference Presentations
From DexCom, Inc.
Via Business Wire
Dexcom Reports Second Quarter 2021 Financial Results
From DexCom, Inc.
Via Business Wire
FDA Clears Dexcom Real-Time APIs for Third-Party Apps and Devices
From DexCom, Inc.
Via Business Wire
Dexcom Schedules Second Quarter 2021 Earnings Release and Conference Call for July 29, 2021 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
Dexcom CGM Plays Starring Role at 81st Scientific Sessions of the American Diabetes Association
From DexCom, Inc.
Via Business Wire
DexCom, Nick Jonas and Leading Diabetes Nonprofits Launch Initiative to Help Improve the Lives of People With Diabetes
From DexCom
Via Business Wire
Endurance Athlete Sébastien Sasseville to Ride Across Canada in Support of JDRF’s Access For All Campaign
From Dexcom, Inc.
Via Business Wire
British Columbia First Province to Cover Dexcom G6 Continuous Glucose Monitoring System for People With Type 1 and Type 2 Diabetes on Intensive Insulin Therapy
From Dexcom, Inc.
Via Business Wire
Dexcom Looks to the Future of Continuous Glucose Monitoring
From DexCom, Inc.
Via Business Wire
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.